1. |
Chang LK, Sarraf D. Tears of the retinal pigment epithelium: an old problem in a new era[J].Retina,2007,27(5):523-534.
|
2. |
Lehmann B, Heimes B, Gutfleisch M, et al. Serous vascularized pigment epithelial detachment in exudative AMD : morphological typing and risk of tears in the RPE[J].Ophthalmologe, 2015,112(1):49-56.
|
3. |
Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments:a study of 40 eyes[J]. Arch Ophthalmol,1990,108(12):1687-1693.
|
4. |
Mendis R, Lois N. Fundus autofluorescence in patients with retinal pigment epithelial (RPE) tears: an in-vivo evaluation of RPE resurfacing[J]. Graefe's Arch Clin Exp Ophthalmol,2014,252(7):1059-1063.
|
5. |
Caramoy A, Fauser S, Kirchhof B. Fundus autofluorescence and spectral-domain optical coherence tomography findings suggesting tissue remodelling in retinal pigment epithelium tear[J]. Br J Ophthalmol,2012,96(9):1211-1216.
|
6. |
Chuang EL, Bird AC. The pathogenesis of tears of the retinal pigment epithelium[J]. Am J Ophthalmol,1988,105(3):285-290.
|
7. |
Goldstein M, Heilweil G, Barak A,et al. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD[J]. Eye, 2005,19(12):1315-1324.
|
8. |
Guber J, Praveen A, Saeed MU.Higher incidence of retinal pigment epithelium tears after ranibizumab in neovascular age-related macular degeneration with increasing pigment epithelium detachment height[J].Br J Ophthalmol,2013,97(11):1486-1487.
|
9. |
Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration[J]. Retina,2007,27(5):535-540.
|
10. |
Comert E, Sullu Y, Birinci H. Retinal pigment epithelium tears following intravitreal ranibizumab injection for neovascular age-related macular degeneration[J]. Acta Ophthalmol,2013,91(5):414-415.
|
11. |
Koh AH, Chen LJ, Chen SJ, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment[J]. Retina, 2013, 33(4):686-716.
|
12. |
Märker DA, Helbig H, Gamulescu MA. Polypoidal choroidal vasculopathy[J]. Klin Monbl Augenheilkd,2012,229(9):882-888.
|
13. |
Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy[J]. Retina,1995,15(2):100-110.
|
14. |
Chen H, Liu K, Chen LJ, et al. Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis[J].Mol Vis,2012,18:816-829.
|
15. |
Shiraga F, Matsuo T, Yokoe S, et al.Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 1999,128(2):147-154.
|
16. |
Pauleikhoff D, L ffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications[J]. Graefe's Arch Clin Exp Ophthalmol,2002,240(7):533-538.
|
17. |
Japanese Study Group of Polypoidal Choroidal Vasculopathy.Criteria for diagnosis of polypoidal choroidal vasculopathy[J].Nihon Ganka Gakkai Zasshi, 2005,109(7):417-427.
|
18. |
Sato T, Ooto S, Suzuki M, et al. Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration[J]. Ophthalmic Surg Lasers Imaging Retina,2015,46(1):87-90.
|
19. |
Nagiel A, Freund KB, Spaide RF, et al. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography[J]. Am J Ophthalmol,2013,156(5):981-988.
|
20. |
Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003,121(10):1392-1396.
|
21. |
Musashi K, Tsujikawa A, Hirami Y, et al. Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2007,143(5):883-885.
|
22. |
Boscia F, Furino C, Sborgia L, et al. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment[J]. Am J Ophthalmol, 2004,138(6):1077-1079.
|
23. |
Chan WM, Lam DS, Lai TY, et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series[J]. Ophthalmology, 2004,111(8):1576-1584.
|
24. |
Srivastava SK, Sternberg P Jr. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia[J]. Retina,2002,22(5):669-671.
|
25. |
Hirami Y, Tsujikawa A, Otani A, et al. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy[J]. Retina,2007,27(3): 335-341.
|
26. |
Prakash M, Han DP. Recurrent bullous retinal detachments from photodynamic therapy for idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2006,142(6):1079-1081.
|
27. |
Akitaka T, Yasuhiko H, Hideo N, et al. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy[J]. Retina,2007,27(7):832-838.
|